Erratum to: KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models

Documenti analoghi

• KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models
  di: Gravina, Giovanni Luca, et al.
  Pubblicazione: (2015)
• XPO1 (CRM1) inhibition represses STAT3 activation to drive a survivin-dependent oncogenic switch in triple negative breast cancer
  di: Cheng, Yan, et al.
  Pubblicazione: (2014)
• KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma
  di: Zheng, Yun, et al.
  Pubblicazione: (2014)
• XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa)
  di: Gravina, Giovanni Luca, et al.
  Pubblicazione: (2014)
• KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-ALL and AML
  di: Etchin, Julia, et al.
  Pubblicazione: (2013)